Skip to content

Multidisciplinary Treatment of Chronic Vulvar Pain

Active, not recruitingNot applicableNCT03640624
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

Vulvodynia (i.e. chronic vulvar pain without identifiable cause) is a heterogeneous clinical entity with a complex multifactorial causation. It is long lasting and difficult to treat, and the general consensus of current guidelines states that patients with vulvodynia benefit from a compound multidisciplinary intervention targeting mucosal hypersensitivity, pelvic muscle floor dysfunction and general pain management. However, there is little empiric evidence to support this recommendation. This will be a randomized controlled trial comparing multidisciplinary treatment with standard care for women with vulvodynia.

Study details

Official title
Multidisciplinary Treatment of Chronic Vulvar Pain - a Randomized Controlled Study
Conditions
Interventions
  • Combination product: Multidisciplinary treatment
  • Combination product: Treatment as usual
Sponsor
Norwegian University of Science and Technology
Collaborators
St. Olavs Hospital
Start date
2018-09-18
Primary completion
2024-11-10
Sex
Female
Age range
from 18 Years
Results posted
No results posted in this snapshot
Countries
Norway
Total sites listed
1

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Women aged 18 years and older * Chronic vulvar pain for ≥3 months of duration Exclusion Criteria: * Insufficient Norwegian skills * Intellectual disability or severe mental disorder * Severe comorbidity making tailored care necessary (such as active cancer treatment)

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT03640624